Data as of Sep 26, 2026 · Based on 4,029,442 AI responses across 13,338 prompts · See how Parse measures this
Click Therapeuticsclicktherapeutics.comClick Therapeutics develops prescription digital therapeutics that deliver software-based treatments to patients via smartphone, prescribed by physicians. Their Click SE platform combines software with pharmacotherapy to create Software-Enhanced Drugs (SEDs) intended to provide added clinical benefit over drugs alone. They validate and commercialize digital treatments across multiple diseases, including FDA-cleared products such as CT-152 (Rejoyn).
Parse Score
No contexts measured yet.
Excerpts where Click Therapeutics appeared in the AI's answer
Click Therapeutics (Clickotine) — Developed by Click Therapeutics , Clickotine is a personalized mobile platform designed to address nicotine addiction through tracking, social support, mindfulness, and cognitive behavioral techniques.
Click Therapeutics (Clickotine) : Clickotine is a comprehensive, personalized smartphone-based digital therapeutic platform
Excerpts where Click Therapeutics appeared in the AI's answer
Click Therapeutics – Developer of prescription digital therapeutics like Rejoyn (cleared for major depressive disorder), which qualifies for use under the 2025/2026 CMS digital mental health billing codes.
Click Therapeutics : Developing software-based interventions for major depressive disorder, schizophrenia, and migraines, Click works closely with health plans
